Target
BCL6
2 abstracts
Abstract
Neoadjuvant pembrolizumab, GX-188E, and GX-I7 in patients with human papillomavirus-16- and/or 18-positive head and neck squamous cell carcinoma: Single-arm, phase 2 trial with single cell transcriptomic analysis and artificial intelligence-powered spatial analysis.Org: Genome Insight Inc., Heavy Ion Research Institute, Korea Advanced Institute of Science and Technology, Lunit Inc.,
Abstract
Unveiling the prognostic significance of BCL6+/CD10+ mantle cell lymphoma: A systematic analysis.Org: Division of Medical Oncology and Hematology, Loma Linda University School of Medicine, Loma Linda, CA, Department of Internal Medicine school of Medicine, University of California San Francisco, Fresno, CA, Loma Linda University Department of Internal Medicine, Loma Linda, CA, Division of Medical Oncology and Hematology, Loma Linda University of Medicine, Loma Linda, CA, Internal medicine, Loma Linda University health, Loma Linda, CA,